Your browser doesn't support javascript.
loading
SRPK3 Is Essential for Cognitive and Ocular Development in Humans and Zebrafish, Explaining X-Linked Intellectual Disability.
Roychaudhury, Arkaprava; Lee, Yu-Ri; Choi, Tae-Ik; Thomas, Mervyn G; Khan, Tahir N; Yousaf, Hammad; Skinner, Cindy; Maconachie, Gail; Crosier, Moira; Horak, Holli; Constantinescu, Cris S; Kim, Tae-Yoon; Lee, Kang-Han; Kyung, Jae-Jun; Wang, Tao; Ku, Bonsu; Chodirker, Bernard N; Hammer, Michael F; Gottlob, Irene; Norton, William H J; Gerlai, Robert; Kim, Hyung-Goo; Graziano, Claudio; Pippucci, Tommaso; Iovino, Emanuela; Montanari, Francesca; Severi, Giulia; Toro, Camilo; Boerkoel, Cornelius F; Cha, Hyo Sun; Choi, Cheol Yong; Kim, Sungjin; Yoon, Je-Hyun; Gilmore, Kelly; Vora, Neeta L; Davis, Erica E; Chudley, Albert E; Schwartz, Charles E; Kim, Cheol-Hee.
Afiliação
  • Roychaudhury A; Department of Biology, Chungnam National University, Daejeon, South Korea.
  • Lee YR; Department of Biology, Chungnam National University, Daejeon, South Korea.
  • Choi TI; Department of Biology, Chungnam National University, Daejeon, South Korea.
  • Thomas MG; The University of Leicester Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behavior, University of Leicester, Leicester, UK.
  • Khan TN; Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Yousaf H; Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Skinner C; Greenwood Genetic Center, Greenwood, SC, USA.
  • Maconachie G; The University of Leicester Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behavior, University of Leicester, Leicester, UK.
  • Crosier M; Division of Ophthalmology and Orthoptics, Health Science School, University of Sheffield, Sheffield, UK.
  • Horak H; Human Developmental Biology Resource, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Constantinescu CS; Department of Neurology, University of Arizona, Tucson, AZ, USA.
  • Kim TY; Academic Unit of Mental Health and Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Lee KH; Cooper Neurological Institute and Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Kyung JJ; Department of Biology, Chungnam National University, Daejeon, South Korea.
  • Wang T; Department of Biology, Chungnam National University, Daejeon, South Korea.
  • Ku B; Department of Biology, Chungnam National University, Daejeon, South Korea.
  • Chodirker BN; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Hammer MF; Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
  • Gottlob I; Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Norton WHJ; BIO5 Institute, University of Arizona, Tucson, AZ, USA.
  • Gerlai R; The University of Leicester Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behavior, University of Leicester, Leicester, UK.
  • Kim HG; Cooper Neurological Institute and Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Graziano C; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
  • Pippucci T; Department of Psychology, University of Toronto Mississauga, Mississauga, ON, Canada.
  • Iovino E; Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
  • Montanari F; Medical Genetics Unit, AUSL Romagna, Cesena, Italy.
  • Severi G; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Toro C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Boerkoel CF; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Cha HS; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Choi CY; NIH Undiagnosed Diseases Program, NIH Office of Rare Diseases Research and NHGRI, Bethesda, MD, USA.
  • Kim S; NIH Undiagnosed Diseases Program, NIH Office of Rare Diseases Research and NHGRI, Bethesda, MD, USA.
  • Yoon JH; Department of Biological Sciences, Sungkyunkwan University, Suwon, South Korea.
  • Gilmore K; Department of Biological Sciences, Sungkyunkwan University, Suwon, South Korea.
  • Vora NL; Department of Microbiology & Molecular Biology, Chungnam National University, Daejeon, South Korea.
  • Davis EE; Department of Oncology Science, University of Oklahoma, Oklahoma City, OK, USA.
  • Chudley AE; Division of Maternal Fetal Medicine, Department of Ob/Gyn, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Schwartz CE; Division of Maternal Fetal Medicine, Department of Ob/Gyn, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kim CH; Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Ann Neurol ; 2024 Jul 29.
Article em En | MEDLINE | ID: mdl-39073169
ABSTRACT

OBJECTIVE:

Intellectual disability is often the outcome of neurodevelopmental disorders and is characterized by significant impairments in intellectual and adaptive functioning. X-linked intellectual disability (XLID) is a subset of these disorders caused by genetic defects on the X chromosome, affecting about 2 out of 1,000 males. In syndromic form, it leads to a broad range of cognitive, behavioral, ocular, and physical disabilities.

METHODS:

Employing exome or genome sequencing, here we identified 4 missense variants (c.475C > G; p.H159D, c.1373C > A; p.T458N, and c.1585G > A; p.E529K, c.953C > T; p.S318L) and a putative truncating variant (c.1413_1414del; p.Y471*) in the SRPK3 gene in 9 XLID patients from 5 unrelated families. To validate SRPK3 as a novel XLID gene, we established a knockout (KO) model of the SRPK3 orthologue in zebrafish.

RESULTS:

The 8 patients ascertained postnatally shared common clinical features including intellectual disability, agenesis of the corpus callosum, abnormal eye movement, and ataxia. A ninth case, ascertained prenatally, had a complex structural brain phenotype. Together, these data indicate a pathological role of SRPK3 in neurodevelopmental disorders. In post-fertilization day 5 larvae (free swimming stage), KO zebrafish exhibited severe deficits in eye movement and swim bladder inflation, mimicking uncontrolled ocular movement and physical clumsiness observed in human patients. In adult KO zebrafish, cerebellar agenesis and behavioral abnormalities were observed, recapitulating human phenotypes of cerebellar atrophy and intellectual disability.

INTERPRETATION:

Overall, these results suggest a crucial role of SRPK3 in the pathogenesis of syndromic X-linked intellectual disability and provide new insights into brain development, cognitive and ocular dysfunction in both humans and zebrafish. ANN NEUROL 2024.

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Ann Neurol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Ann Neurol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Coréia do Sul